Literature DB >> 22044918

Effects of phenothiazine-class antipsychotics on the function of α7-nicotinic acetylcholine receptors.

Abrar Ashoor1, Dietrich Lorke, Syed M Nurulain, Lina Al Kury, Georg Petroianu, Keun-Hang Susan Yang, Murat Oz.   

Abstract

The effects of phenothiazine-class antipsychotics (chlorpromazine, fluphenazine, phenothiazine, promazine, thioridazine, and triflupromazine) upon the function of the cloned α₇ subunit of the human nicotinic acetylcholine receptor expressed in Xenopus oocytes were tested using the two-electrode voltage-clamp technique. Fluphenazine, thioridazine, triflupromazine, chlorpromazine, and promazine reversibly inhibited acetylcholine (100 μM)-induced currents with IC₅₀ values of 3.8; 5.8; 6.1; 10.6 and 18.3 μM, respectively. Unsubstituted phenothiazine did not have a significant effect up to a concentration of 30 μM. Inhibition was further characterized using fluphenazine, the strongest inhibitor. The effect of fluphenazine was not dependent on the membrane potential. Fluphenazine (10 μM) did not affect the activity of endogenous Ca²⁺-dependent Cl⁻ channels, since the extent of inhibition by fluphenazine was unaltered by intracellular injection of the Ca²⁺ chelator BAPTA and perfusion with Ca²⁺-free bathing solution containing 2 mM Ba²⁺. Inhibition by fluphenazine, but not by chlorpromazine was reversed by increasing acetylcholine concentrations. Furthermore, specific binding of [¹²⁵I] α-bungarotoxin, a radioligand selective for α₇-nicotinic acetylcholine receptor, was inhibited by fluphenazine (10 μM), but not by chlorpromazine in oocyte membranes. In hippocampal slices, epibatidine-evoked [³H] norepinephrine release was also inhibited by fluphenazine (10 μM) and chlorpromazine (10 μM). Our results indicate that phenothiazine-class typical antipsychotics inhibit, with varying potencies, the function of α₇-nicotinic acetylcholine receptor.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22044918     DOI: 10.1016/j.ejphar.2011.10.020

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  3 in total

1.  Synthesis and structural properties of 2-((10-alkyl-10H-phenothiazin-3-yl)methylene)malononitrile derivatives; a combined experimental and theoretical insight.

Authors:  Fatimah Ali Al-Zahrani; Muhammad Nadeem Arshad; Abdullah M Asiri; Tariq Mahmood; Mazhar Amjad Gilani; Reda M El-Shishtawy
Journal:  Chem Cent J       Date:  2016-03-15       Impact factor: 4.215

2.  Acepromazine inhibits hERG potassium ion channels expressed in human embryonic kidney 293 cells.

Authors:  Young Shin Joo; Hong Joon Lee; Jin-Sung Choi; Ki-Wug Sung
Journal:  Korean J Physiol Pharmacol       Date:  2016-12-21       Impact factor: 2.016

3.  Receptor variants and the development of centrally acting medications
.

Authors:  Stuart A Neale; Kumiko Kambara; Thomas E Salt; Daniel Bertrand
Journal:  Dialogues Clin Neurosci       Date:  2019       Impact factor: 5.986

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.